Workflow
华峰化学(002064):一季度业绩承压,增强一体化优势

Investment Rating - The report maintains a "Strong Buy" rating for Huafeng Chemical [2][4]. Core Views - The company's Q1 performance was under pressure due to a decline in product prices, with revenue at 6.314 billion yuan, down 5.15% year-on-year, and net profit at 504 million yuan, down 26.21% year-on-year [3]. - Despite short-term challenges, the recovery in spandex prices since 2025 is expected to alleviate operational pressures for spandex manufacturers [3]. - Huafeng Chemical has a strong scale advantage, being the second-largest spandex producer globally and the largest in China, with significant production capacities in adipic acid and polyurethane [3]. - The company is expanding its production capacity, with ongoing projects expected to enhance its scale advantage further [3]. - Investments in upstream raw material projects are anticipated to strengthen the company's cost advantages in the spandex industry [4]. Financial Performance Summary - For 2025, the company forecasts net profits of 2.133 billion yuan, with earnings per share (EPS) of 0.43 yuan, and a price-to-earnings (P/E) ratio of 16 [4][5]. - Revenue is projected to grow from 26.298 billion yuan in 2023 to 33.293 billion yuan in 2027, reflecting a compound annual growth rate (CAGR) of approximately 8.56% [5]. - The net profit is expected to decline slightly in 2025 before recovering in subsequent years, with a forecast of 2.664 billion yuan by 2027 [5]. Company Overview - Huafeng Chemical is a leading manufacturer of spandex fibers, adipic acid, and polyurethane raw materials, with a comprehensive product range that meets diverse customer needs [6]. - The company has established itself as a top player in the chemical fiber industry, recognized for its efficiency and product quality [6].